A medical survey has found major gender differences in research, diagnosis and treatment of cardiovascular disease.
The focus of the European Society of Cardiology annual congress 2005 is to improve understanding of and address issues surrounding women and cardiovascular disease (CDV). The congress examined the results of the Euro Heart Survey considering gender differences and found that major differences exist in the diagnosis and treatment of CDV between men and women. Women are less likely to be investigated for heart disease than men – and when they are, they are already more sick and do less well in treatment.
Heart disease is the biggest cause of death for men and women in the European Union. More women die of cardiovascular disease than of all cancers (including breast cancer) combined. The Commission’s Heart Health Conference held in June 2005 resulted in a plan to promote cardiovascular disease (CVD) prevention measures across Europe.
EU official documents
- Heart Health Conference:Luxembourg Declaration(29 June 2005)
- World Health Organisation:Gender
EU Actors positions
- European Society of Cardiology - 2005 Congress press release:Women at Heart: Stop the Bias - If guidelines do not discriminate between men and women, why do we do so in clinical practice? Results of the Euro Heart Surveys(4 September 2005)
- European Society of Cardiology press release:Women missing out in heart treatment – more needed in clinical trials(2 August 2005)
- European Society of Cardiology press release:ESC Congress 2005 to utilise studies, sessions and sunshine to shed light on women and CVD(21 June 2005)
- European Society of Cardiology:Women at Heart -initiative
- BBC News:Heart disease missed in women
- Telegraph.co.ukHeart disease 'a bigger killer in women than men'
- ic Wales:Female heart disease victims 'ignored' by professionals